ZNRF3 in neurodevelopmental disorders: insights into Wnt signaling and therapeutic potential.

This review looks at a gene called ZNRF3 that helps control how brain cells grow and connect. Changes in this gene may contribute to autism, ADHD, and intellectual disabilities by affecting how brain cells develop and communicate. The researchers discuss how factors before birth and healthcare policies can impact diagnosis and treatment. They suggest better genetic testing, early support, and improved policies could help provide more personalized care for people affected by problems with this gene.

This review examines the role of ZNRF3, a gene involved in Wnt signaling, in neurodevelopmental disorders including autism spectrum disorder, ADHD, and intellectual disabilities. The authors synthesize genetic, molecular, and clinical research to understand how ZNRF3 regulates neural cell growth and connectivity during brain development. Variations in this gene are linked to disruptions in neural differentiation and communication. The review also explores how prenatal environmental exposures and healthcare policies impact diagnostic practices and treatment accessibility.

The findings emphasize the importance of improved genetic screening, early intervention strategies, and policy reforms to enable personalized care for individuals with ZNRF3-related neurodevelopmental disorders.

This research suggests genetic screening for ZNRF3 variations could aid in early identification and personalized treatment planning for neurodevelopmental disorders. The findings support the development of targeted early intervention strategies and highlight the need for policy reforms to improve diagnostic accessibility and personalized care approaches.

As a review article, findings depend on the quality and scope of included studies. No sample size reported, making it difficult to assess the breadth of evidence synthesized. The abstract does not specify the methodology used for study selection or quality assessment.

Neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), attention-deficit hyperactivity disorder (ADHD), and intellectual disabilities (ID), have seen an increasing prevalence in recent years. Both genetic and environmental factors have been implicated in the pathogenesis of these conditions. One such gene, ZNRF3, plays a pivotal role in regulating neural cell growth and connectivity, with variations in this gene linked to disruptions in neural differentiation and communication. This review synthesizes genetic, molecular, and clinical research to examine the role of ZNRF3 in brain development.

Furthermore, it explores the impact of prenatal environmental exposures and healthcare policies on diagnostic practices and treatment accessibility. The findings highlight the need for improved genetic screening, early intervention strategies, and policy reforms aimed at facilitating personalized care for individuals affected by ZNRF3-related NDDs.